Does SEVOFLURANE Cause Hyperthermia malignant? 207 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Hyperthermia malignant have been filed in association with SEVOFLURANE (Sojourn). This represents 4.8% of all adverse event reports for SEVOFLURANE.
207
Reports of Hyperthermia malignant with SEVOFLURANE
4.8%
of all SEVOFLURANE reports
15
Deaths
96
Hospitalizations
How Dangerous Is Hyperthermia malignant From SEVOFLURANE?
Of the 207 reports, 15 (7.2%) resulted in death, 96 (46.4%) required hospitalization, and 64 (30.9%) were considered life-threatening.
Is Hyperthermia malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEVOFLURANE. However, 207 reports have been filed with the FAERS database.
What Other Side Effects Does SEVOFLURANE Cause?
Hypotension (316)
Anaesthetic complication neurological (260)
Acute kidney injury (212)
Cardiac arrest (159)
Tachycardia (159)
Bradycardia (155)
Drug ineffective (147)
Oxygen saturation decreased (129)
Post procedural complication (129)
Anaphylactic shock (123)
What Other Drugs Cause Hyperthermia malignant?
SUCCINYLCHOLINE (276)
PROPOFOL (205)
FORANE (170)
ROCURONIUM (114)
FENTANYL (107)
SEVOFLURANE, USP (93)
ISOFLURANE (87)
MIDAZOLAM (62)
CISATRACURIUM (60)
SUFENTANIL (56)
Which SEVOFLURANE Alternatives Have Lower Hyperthermia malignant Risk?
SEVOFLURANE vs SEVOFLURANE, USP
SEVOFLURANE vs SIBUTRAMINE
SEVOFLURANE vs SILDENAFIL
SEVOFLURANE vs SILODOSIN
SEVOFLURANE vs SILTUXIMAB